Getein Biotech Inc Asset Resilience Ratio

Latest as of March 2026: 29.77%

Getein Biotech Inc asset resilience ratio. Getein Biotech Inc (603387) has an Asset Resilience Ratio of 29.77% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Getein Biotech Inc fund operations to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥1.10 Billion

≈ $161.12 Million USD Cash + Short-term Investments

Total Assets

CN¥3.70 Billion

≈ $541.26 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Getein Biotech Inc (2016–2025)

Asset resilience ratio of Getein Biotech Inc from 2016 to 2025. This chart shows how Getein Biotech Inc's Asset Resilience Ratio has changed over time. Read how much debt does Getein Biotech Inc carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Getein Biotech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Getein Biotech Inc.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.10 Billion	29.77%
Total Liquid Assets	CN¥1.10 Billion	29.77%

Asset Resilience Insights

Very High Liquidity: Getein Biotech Inc maintains exceptional liquid asset reserves at 29.77% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Getein Biotech Inc Industry Peers by Asset Resilience Ratio

Compare Getein Biotech Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Demant A/S CO:DEMANT	Medical Devices	-2.59%
Shanghai Sanyou Medical Co Ltd SHG:688085	Medical Devices	7.69%
CareRay Digital Medical Technology Co Ltd SHG:688607	Medical Devices	16.21%
Cleo Diagnostics Ltd AU:COV	Medical Devices	94.64%
Memphasys Ltd AU:MEM	Medical Devices	0.00%
Cochlear Ltd AU:COH	Medical Devices	9.76%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%
Polynovo Ltd AU:PNV	Medical Devices	0.04%

Getein Biotech Inc Asset Resilience Ratio by Year (2016–2025)

Getein Biotech Inc asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Getein Biotech Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	24.30%	CN¥912.63 Million ≈ $133.55 Million	CN¥3.76 Billion ≈ $549.61 Million	+6.80pp
2024-12-31	17.50%	CN¥648.88 Million ≈ $94.95 Million	CN¥3.71 Billion ≈ $542.51 Million	+5.52pp
2023-12-31	11.98%	CN¥451.91 Million ≈ $66.13 Million	CN¥3.77 Billion ≈ $551.91 Million	-1.92pp
2022-12-31	13.90%	CN¥511.14 Million ≈ $74.80 Million	CN¥3.68 Billion ≈ $538.12 Million	-5.63pp
2021-12-31	19.52%	CN¥612.68 Million ≈ $89.65 Million	CN¥3.14 Billion ≈ $459.18 Million	-2.51pp
2020-12-31	22.03%	CN¥594.92 Million ≈ $87.06 Million	CN¥2.70 Billion ≈ $395.09 Million	-1.24pp
2019-12-31	23.28%	CN¥467.36 Million ≈ $68.39 Million	CN¥2.01 Billion ≈ $293.78 Million	-26.79pp
2017-12-31	50.07%	CN¥634.14 Million ≈ $92.79 Million	CN¥1.27 Billion ≈ $185.34 Million	+11.58pp
2016-12-31	38.49%	CN¥167.08 Million ≈ $24.45 Million	CN¥434.09 Million ≈ $63.52 Million	--

pp = percentage points

About Getein Biotech Inc

SHG:603387 China Medical Devices

Market Cap

$631.55 Million

CN¥4.32 Billion CNY

Market Cap Rank

#10739 Global

#2898 in China

Share Price

CN¥8.51

Change (1 day)

-2.41%

52-Week Range

CN¥7.52 - CN¥10.65

All Time High

CN¥21.49